[en] antiplatelet drugs are the cornerstone
treatment in the secondary prevention of arterial
thrombosis. Until recently, their intake was interrupted
in the perioperative period because of fear
for bleeding, but new insights have challenged this
old habit. in patients at high risk for atherothrombotic
events who need to undergo surgery or an
invasive procedure, the risk for bleeding complications
because of a treatment with low-dose acetylsalicylic
acid (lD aSa) needs to be balanced
against the risk of atherothrombotic events after
treatment discontinuation. for patients at high risk
of atherothrombotic complications recent guidelines
do no longer advocate to interrupt lD aSa
routinely. However, the likelihood of bleeding versus
atherothrombotic complications should be considered
on a case-by-case basis. when continued
perioperatively, the bleeding risk associated with
thienopyridines (ticlopidine, clopidogrel and prasugrel)
is higher than that of lD aSa. it is recommended
to stop their intake 1 week before the surgical
intervention, except in patients with (recent) coronary stenting
Disciplines :
Surgery
Author, co-author :
Engelen, S.
Sinaeve, P.
Van Damme, Hendrik ; Université de Liège - ULiège > Chirurgie cardio-vasculaire
Davi, G., Patrono, C., Platelet activation and atherothrombosis (2007) N. Engl. J. Med., 357 (24), pp. 2482-2494
Baigent, C., Blackwell, L., Collins, R., Emberson, J., Godwin, J., Peto, R., Aspirin in the primary and secondary prevention of vascular disease: Collaborative meta-analysis of individual participant data from randomised trials (2009) Lancet, 373 (9678), pp. 1849-1860
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients (2002) BMJ, 324 (7329), pp. 71-86
Patrono, C., Bachmann, F., Baigent, C., Bode, C., De Caterina, R., Charbonnier, B., Fitzgerald, D., Wallentin, L., Expert Consensus Document on the Use of Antiplatelet Agents: The Task Force on the Use of Antiplatelet Agents in Patients with Atherosclerotic Cardiovascular Disease of the European Society of Cardiology (2004) European Heart Journal, 25 (2), pp. 166-181. , DOI 10.1016/j.ehj.2003.10.013
Douketis, J.D., Berger, P.B., Dunn, A.S., Jaffer, A.K., Spyropoulos, A.C., Becker, R.C., Ansell, J.E., The perioperative management of antithrombotic therapy: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition) (2008) Chest, 133 (6 SUPPL. 6), pp. 299S-339S. , DOI 10.1378/chest.08-0675
Spyropoulos, A.C., Douketis, J.D., Guidelines for antithrombotic therapy: Periprocedural management of antithrombotic therapy and use of bridging anticoagulation (2008) Int. Angiol., 27 (4), pp. 333-343
Merritt, J.C., Bhatt, D.L., The efficacy and safety of perioperative antiplatelet therapy (2004) Journal of Thrombosis and Thrombolysis, 17 (1), pp. 21-27. , DOI 10.1023/B:THRO.0000036025.07348.f1, Special Issue on Vascular Disease: Contemporaray Thoughts on the Disease and the Management Strategies
Topol, E.J., Aspirin with bypass surgery - From taboo to new standard of care (2002) New England Journal of Medicine, 347 (17), pp. 1359-1360. , DOI 10.1056/NEJMe020114
Krupski, W.C., Update on perioperative evaluation and management of cardiac disease in vascular surgery patients (2002) Journal of Vascular Surgery, 36 (6), pp. 1292-1308. , DOI 10.1067/mva.2002.129647
Clarke, R.J., Mayo, G., Price, P., FitzGerald, G.A., Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin (1991) N. Engl. J. Med., 325 (16), pp. 1137-1141
Roth, G.J., Majerus, P.W., The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein (1975) J. Clin. Invest., 56 (3), pp. 624-632
Vilahur, G., Choi, B.G., Zafar, M.U., Viles-Gonzalez, J.F., Vorchheimer, D.A., Fuster, V., Badimon, J.J., Normalization of platelet reactivity in clopidogrel-treated subjects (2007) Journal of Thrombosis and Haemostasis, 5 (1), pp. 82-90. , DOI 10.1111/j.1538-7836.2006.02245.x
Patrono, C., Baigent, C., Hirsh, J., Roth, G., Antiplatelet drugs: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition) (2008) Chest, 133 (6 SUPPL. 6), pp. 199S-233S. , DOI 10.1378/chest.08-0672
Bhatt, D.L., Bertrand, M.E., Berger, P.B., L'Allier, P.L., Moussa, I., Moses, J.W., Dangas, G., Topol, E.J., Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting (2002) Journal of the American College of Cardiology, 39 (1), pp. 9-14. , DOI 10.1016/S0735-1097(01)01713-2, PII S0735109701017132
Hochholzer, W., Trenk, D., Frundi, D., Blanke, P., Fischer, B., Andris, K., Bestehorn, H.-P., Neumann, F.-J., Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention (2005) Circulation, 111 (20), pp. 2560-2564. , DOI 10.1161/01.CIR.0000160869.75810.98
Patrono, C., Garcia, R.L.A., Landolfi, R., Baigent, C., Low-dose aspirin for the prevention of atherothrombosis (2005) New England Journal of Medicine, 353 (22), pp. 2373-2383. , http://content.nejm.org/cgi/reprint/353/22/2373.pdf, DOI 10.1056/NEJMra052717
Beving, H., Zhao, C., Albage, A., Ivert, T., Abnormally high platelet activity after discontinuation of acetylsalicylic acid treatment (1996) Blood Coagulation and Fibrinolysis, 7 (1), pp. 80-84
Collet, J.P., Montalescot, G., Blanchet, B., Tanguy, M.L., Golmard, J.L., Choussat, R., Beygui, F., Thomas, D., Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes (2004) Circulation, 110 (16), pp. 2361-2367. , DOI 10.1161/01.CIR.0000145171.89690.B4
Maulaz, A.B., Bezerra, D.C., Michel, P., Bogousslavsky, J., Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke (2005) Archives of Neurology, 62 (8), pp. 1217-1220. , http://archneur.ama-assn.org/cgi/reprint/62/8/1217.pdf, DOI 10.1001/archneur.62.8.1217
Ambrose, J.A., Fuster, V., The risk of coronary occlusion is not proportional to the prior severity of coronary stenoses (1998) Heart, 79 (1), pp. 3-4
Burger, W., Chemnitius, J.-M., Kneissl, G.D., Rucker, G., Low-close aspirin for secondary cardiovascular prevention - Cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - Review and meta-analysis (2005) Journal of Internal Medicine, 257 (5), pp. 399-414. , DOI 10.1111/j.1365-2796.2005.01477.x
Mangano, D.T., Aspirin and mortality from coronary bypass surgery (2002) New England Journal of Medicine, 347 (17), pp. 1309-1317. , DOI 10.1056/NEJMoa020798
Schouten, O., Bax, J.J., Poldermans, D., Management of patients with cardiac stents undergoing noncardiac surgery (2007) Current Opinion in Anaesthesiology, 20 (3), pp. 274-278. , DOI 10.1097/ACO.0b013e328105dac5, PII 0000150320070600000022
Ferrari, E., Benhamou, M., Cerboni, P., Marcel, B., Coronary syndromes following aspirin withdrawal: A special risk for late stent thrombosis (2005) Journal of the American College of Cardiology, 45 (3), pp. 456-459. , DOI 10.1016/j.jacc.2004.11.041, PII S0735109704024076
Vicenzi, M.N., Meislitzer, T., Heitzinger, B., Halaj, M., Fleisher, L.A., Metzler, H., Coronary artery stenting and non-cardiac surgery - A prospective outcome study (2006) Br. J. Anaesth., 96 (6), pp. 686-693. , Jun
Vandermeulen, E., Regional anaesthesia and anticoagulation (2010) Best. Pract. Res. Clin. Anaesthesiol., 24 (1), pp. 121-131
Gogarten, W., Vandermeulen, E., Van, A.H., Kozek, S., Llau, J.V., Samama, C.M., Regional anaesthesia and anti-thrombotic agents: Recommendations of the European Society of Anaesthesiology (2010) Eur. J. Anaesthesiol.
